A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708)

Japanese Journal of Clinical Oncology

Volumn 39, Issue 10, 2009, Pages 638-643

  Kato, Hoichi ^a   Sato, Akihiro ^b   Fukuda, Haruhiko ^a   Kagami, Yoshikazu ^a   Udagawa, Harushi ^c   Togo, Akihiko ^d   Ando, Nobutoshi ^e   Tanaka, Otsuo ^f   Shinoda, Masayuki ^g   Yamana, Hideaki ^h   Ishikura, Satoshi ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c Toranomon General Hospital   (Japan)

^d Togo Clinic   (Japan)

^e TOKYO DENTAL COLLEGE   (Japan)

^f Niigata Cancer Center   (Japan)

^g AICHI CANCER CENTER HOSPITAL   (Japan)

^h KURUME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Clinical trial; Combined modality therapy; Esophageal neoplasms; Phase II; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE;

ADULT; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DYSPNEA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS RESECTION; FEMALE; FEVER; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; JAPAN; LEUKOCYTE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPHIL; OVERALL SURVIVAL; OXYGEN TENSION; PERICARDITIS; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; RADIATION FIELD; SALVAGE THERAPY; SENSORY NEUROPATHY; SIDE EFFECT; STOMATITIS; SURVIVAL TIME; THROMBOCYTE; ESOPHAGUS TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM STAGING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349975980     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp069     Document Type: Article

References (15)

1. Kato H, Tachimori Y, Mizobuchi S, Igaki H, Ochiai A. Cervical, mediastinal, and abdominal lymph node dissection (three-field dissection) for superficial carcinoma of the thoracic esophagus. Cancer 1993;72:2879-82.
2. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 1995;76:178-86.
3. Kato H, Tachimori Y, Watanabe H, Iizuka T. Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int J Cancer 1993;53:220-3.
4. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216:583-90.
5. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
6. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999;17:2915-21.
7. Petrovich Z, Langholz B, Formenti S, Luxton G, Astrahan M. Management of carcinoma of the esophagus: The role of radiotherapy. Am J Clin Oncol 1991;14:80-6.
8. Okawa T, Tanaka M, Kita M, Kaneyasu Y, Karasawa K, Ide H, et al. Radiotherapy for superficial esophageal cancer. Int J Radiat Oncol Biol Phys 1994;30:959-64.
9. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991;20:29-36.
10. International Union Against Cancer. TNM Classification of Malignant Tumours. 4th edn. New York: John Wiley & Sons, Inc. 1987.
11. Simon R. Design and conduct of clinical trials. In: Cancer-Principles and Practice of Oncology. Philadelphia: J.B. Lippincott Company 1993.
12. Tobinai K, Kohno A, Shimada Y, Watanabe T, Tamura T, Takeyama K, et al. Toxicity grading criteria of the Japan Clinical Oncology Group. The Clinical Trial Review Committee of the Japan Clinical Oncology Group. Jpn J Clin Oncol 1993;23:250-7.
13. Hoff SJ, Stewart JR, Sawyers JL, Murray MJ, Merrill WH, Adkins RB, et al. Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993;56:282-6; discussion 6-7.
14. Igaki H, Kato H, Tachimori Y, Daiko H, Fukaya M, Yajima S, et al. Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 2001;20:1089-94.
15. Coia LR. Chemoradiation as primary management of esophageal cancer. Semin Oncol 1994;21:483-92.